BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15169607)

  • 1. Simian virus-40 as a gene therapy vector.
    Vera M; Fortes P
    DNA Cell Biol; 2004 May; 23(5):271-82. PubMed ID: 15169607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the production of recombinant SV40 vectors.
    Vera M; Prieto J; Strayer DS; Fortes P
    Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy using SV40-derived vectors: what does the future hold?
    Strayer DS
    J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.
    Strayer D; Branco F; Zern MA; Yam P; Calarota SA; Nichols CN; Zaia JA; Rossi J; Li H; Parashar B; Ghosh S; Chowdhury JR
    Mol Ther; 2002 Aug; 6(2):227-37. PubMed ID: 12161189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
    Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
    Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can SV40-derived vectors do for gene therapy?
    Strayer DS; Zern MA; Chowdhury JR
    Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titering replication-defective rSV40 vectors.
    Strayer DS; Mitchell C; Maier DA; Nichols CN
    Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5437. PubMed ID: 20516175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
    Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
    J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of SV40-derived vectors.
    Strayer DS; Mitchell C; Maier DA; Nichols CN
    Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5436. PubMed ID: 20516174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
    Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
    Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors.
    Liu B; Daviau J; Nichols CN; Strayer DS
    Blood; 2005 Oct; 106(8):2655-62. PubMed ID: 15994284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells.
    Strayer DS; Kondo R; Milano J; Duan LX
    Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of recombinant SV40-based vectors for gene therapy.
    Buscail L; Cordelier P
    Recent Pat DNA Gene Seq; 2007; 1(2):93-9. PubMed ID: 19075921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene transfer to the CNS using recombinant SV40-derived vectors.
    Louboutin JP; Agrawal L; Liu B; Strayer DS
    Expert Opin Biol Ther; 2008 Sep; 8(9):1319-35. PubMed ID: 18694352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis B.
    Matskevich AA; Cordelier P; Strayer DS
    J Interferon Cytokine Res; 2003 Dec; 23(12):709-21. PubMed ID: 14769147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.
    Kimchi-Sarfaty C; Gottesman MM
    Curr Pharm Biotechnol; 2004 Oct; 5(5):451-8. PubMed ID: 15544493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats.
    Sauter BV; Parashar B; Chowdhury NR; Kadakol A; Ilan Y; Singh H; Milano J; Strayer DS; Chowdhury JR
    Gastroenterology; 2000 Nov; 119(5):1348-57. PubMed ID: 11054394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids.
    Nakanishi A; Chapellier B; Maekawa N; Hiramoto M; Kuge T; Takahashi RU; Handa H; Imai T
    Virology; 2008 Sep; 379(1):110-7. PubMed ID: 18667220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.